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Abstract: The aim of the present study was to monitor implant stability after sinus floor elevation
with two biomaterials during the first six months of healing by resonance frequency analysis (RFA),
and how physico-chemical properties affect the implant stability quotient (ISQ) at the placement and
healing sites. Bilateral maxillary sinus augmentation was performed in 10 patients in a split-mouth
design using a bobine HA (BBM) as a control and porcine HA (PBM). Six months after sinus lifting,
60 implants were placed in the posterior maxilla. The ISQ was recorded on the day of surgery from
RFA at T1 (baseline), T2 (three months), and T3 (six months). Statistically significant differences were
found in the ISQ values during the evaluation period. The ISQ (baseline) was 63.8 ± 2.97 for BBM
and 62.6 ± 2.11 for PBM. The ISQ (T2) was ~73.5 ± 4.21 and 67 ± 4.99, respectively. The ISQ (T3)
was ~74.65 ± 2.93 and 72.9 ± 2.63, respectively. All of the used HAs provide osseointegration and
statistical increases in the ISQ at baseline, T2 and T3 (follow-up), respectively. The BBM, sintered
at high temperature with high crystallinity and low porosity, presented higher stability, which
demonstrates that variations in the physico-chemical properties of a bone substitute material clearly
influence implant stability.
Keywords: hydroxyapatite; xenografts; implant design; implant surface
1. Introduction
The edentulous ridge in the posterior maxilla often presents a limited bone volume due to both a
lack of alveolar bone after ridge remodeling and maxillary sinus pneumatization [1]. Adequate alveolar
ridges play a crucial role when it comes to rehabilitation with implants, and some augmentation
technique is necessary for patients who suffer from alveolar atrophy [2]. The most predictable and
commonly used means of facilitating implant therapy in the atrophic posterior maxilla has been
sinus augmentation [3]. Although alternatives, e.g., using shorter implants, are beginning to be
investigated [4–6], any available scientific evidence is modest and insufficient to conclude that the
success of sinus lift procedures in bone with a residual height between 4 mm and 9 mm will be better,
or not, than when short implants are used [7,8]. Maxillary sinus floor grafting has become the most
common surgical intervention when increasing alveolar bone height before placing endosseous dental
implants in the posterior maxilla [9].
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Several factors influence maxillary sinus floor grafting results: specific surgical techniques,
a simultaneous versus a delayed procedure, using barrier membranes over the lateral window, implant
surface characteristics, the length and width of implants, and selecting the graft material [10].
As regards the last factor/variable, researchers have not reached an agreement about the
most suitable material for sinus augmentation [11]. In the clinical practice, the main purpose of
bone augmentation procedures is bone formation, where implants are positioned to best support
prosthetic rehabilitation. The bone tissue around dental implants must be mechanically competent
after augmentation procedures [12].
Today not many controlled research works evaluate the use of different bone grafting materials
for sinus augmentation. Sinus elevation, performed with a wide variety of different graft materials,
has been used. However, it still remains unclear which is the most suitable bone grafting material for
enhancing bone regeneration in the augmented sinus [13,14]. Deproteinized xenografts, constituted
primarily of natural apatites, which are either sintered or not, have good physical and physico-chemical
properties. Deproteinization is an indispensable process followed to eliminate antigenicity in
xenograft bones. Different physicochemical conditions selectively modulate the host organism’s
tissue response [15]. Some authors have reported the same observations in reaction to the microscopic
structure in commercial products subjected to thermal deproteinization processes [16,17]. The sintering
temperature is considered an important factor that might alter the HA´s characteristics [18]. However,
the sintering temperature effect on the physico-chemical properties of natural HA (HA of a natural
source), especially HA from bovine bone, is still not fully understood and research in this area is still
wide open.
The ultra-structural interface of the graft bone tissue interface, as well as the ideal time point of
placing implants, have not yet been described [19].
Typical surgical protocols are simultaneous one-stage lateral or crestal antrostomy when the
residual crestal bone is greater than 3–6 mm, or a two-stage delayed procedure, which is recommended
when the residual bone is less than 3–6 mm. Furthermore, the risk of implant failure is halved when
the two-stage technique is used [20].
The graft consolidation gradient reflects the features of each bone substitute at sinus augmentation
sites [21]. According to some studies, the physico-chemical properties of each bone material graft may
influence the osteointegration process, and this influence may result in shorter healing times between
implant placement and restoration. Therefore, a profound understanding of not only the different
aspects of biomaterial properties, but also of their relation to and influence on bone healing has proved
to be of utmost importance [22].
An undisturbed healing period of at least 3–6 months at surgical sites is the generally accepted
protocol after implant placement. This can ensure uneventful healing and improve osseointegration
between the implant and bone. The reason for this approach is based on the fact that the functional force
around the bone-implant interface causes implant micromotion during wound healing, while implant
micromotion may induce fibrous tissue rather than bone contact, which results in clinical failure.
All of these concerns about waiting periods have long since been a challenge for both patients and
clinicians. Changing trends and demands have rendered the introduction of early loading techniques
necessary as a result of searching for faster dental function restoration using implants [23]. Successful
osseointegration is a prerequisite for functional dental implants; absence of osseointegration has been
reported for implants with no primary stability [24].
Implant stability can be defined as the combination of both mechanical and biological stability.
While mechanical stability appears as the result of bone tissue compression during implantation,
biological stability is obtained as a result of the formation of new bone cells on the implant surface
during the osseointegration process. Hence implant stability is associated with the quality and quantity
of local bone [25]. Nowadays, the technique most frequently used to detect implant stability during
healing times and in subsequent follow-ups is the non invasive diagnostic tool known as resonance
frequency analysis (RFA) [26,27]. Continuous monitoring at various time points is important to
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determine the implant stability status and to estimate a long-term prognosis for successful therapy [28].
Evaluating bone density has long since been one of the most important parameters to quantify bone
quality as it is thought to be a major determinant of primary stability. In other words, primary implant
stability is dependent on not only the thickness of the bone into which the implant is placed, but also
on bone density. Therefore, all these factors should be taken into account when making the clinical
decision to perform a one-stage or a two-stage procedure [29]. The level of bone density at the implant
site could be of utmost importance as it is related with failure rates and primary stability. When
it comes to evaluating primary implant stability in relation with bone density, the implant stability
quotient (ISQ) and the resonance frequency analysis can be used [30]. The primary stability of a dental
implant, absence of mobility at the osseous site after implant insertion, and the quality of the receptor
bone site are highly correlated. Likewise, primary stability is also strictly correlated to the mechanical
relationship between the implant surface and the recipient bone. This relationship can determine
implant placement outcomes by avoiding micromovements on the interface [31].
Optimal outcomes in implant survival terms have been demonstrated for implants placed in the
maxillary sinus filled with deproteinized bovine bone mineral, and this material can be considered
a safe predictable graft material for sinus floor augmentation [32]. However, very little is known
about the physico-chemical properties of used grafts and the impact on both bone density and early
implant stability after they have been employed. The aim of this randomized split-mouth design was
to compare the stability of dental implants placed after sinus floor elevation with two HAs during
the first six months of healing by means of RFA, and to monitor how the physico-chemical properties
affect the implant stability quotient (ISQ) at the placement and healing sites.
2. Results
2.1. Graft Implants Characterization
Figure 1 shows the xenograft materials before inserting for maxillary sinus floor elevation.
The BBM (bovine bone material) consists of HA particles of 500–1000 µm on average, with rounded
edges and pores of 100 µm on average. The PBM (porcine bone material) consists of HA and collagen
particles of 600–1000 µm on average. A summary of the microstructural parameter studied in a previous
paper is shown in Table 1 to provide a better understanding of the materials´ microstructure [33].
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Figure 1. Scanning electron micrographs of (A) the BBM and (B) PBM xenograft materials
before implantation.
Table 1. Physical properties of the two xenograft materials [33].
Material Phase/s Ca/P Ratio ParticleSize (µm)
Crystal
Size (nm)
Real Density
(g/cc)
Porosity
(%)
Surface Area
(m2/g)
PBM HA+Coll 2.22 ± 0.08 600–1000 325 2.85 59.90 97.84
BBM HA 2.31 ± 0.09 500–1000 732 2.98 49.13 2.77
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2.2. Radiological and Thermographic Results
After a six-month follow-up period of our ten partially-edentulous patients treated with xenograft
materials for sinus floor augmentation, the success rate was 100%. No sinus membrane perforation or
other clinical complications, such as sinusitis or pain, resulted from surgery. The increased volumes
produced by the xenograft procedures were stable by the end of the healing period, as seen in Figure 2.
Deproteinized bone particles of two different temperatures induced osteoconduction six months
after implantation.
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Figure 2. The i-C T Vision postoperative image shows the increased volumes produced by the
xenograft procedures 6 months after maxillary sinus elevation with a porcine hydroxyapatite (axial
cuts 24–42) and a bovine hydroxyapatite (axial cuts −38 to −20)( b = Buccal side).
Bone density at the implant site could be crucial as it has been reported to correlates with failure
rates and primary stability. The bone density in the grafted area with both biomaterials was evaluated
radiologically as a routine diagnostic approach. Color thermal graduation was used to observe
changes in radiopacity in the intrasinus bone grafted area. At the time of implant insertion, and after
a six-month healing period, the ugmentation sites tr ated with th PBM showed denser new bone
formation, which was achieved along the inner surfac of the replac d bony window than the area on
the bone graft (Figu e 3A,B). The BBM shows that denser new bone formation was achieved in th area
on th bone graft comp red to the original augmentation density (Figure 3C,D). The bone area differed
in the grou s aft impla tation and increased with time. Bone initially formed n the sinus wall and
proliferated into the center of the augmented sinus cavity. Newly-formed bone came consistently into
close contact with particles, and no gaps were present on the bone particle interface. Particles appeared
to act as a scaffold by supporting new bone formation. Scaffolding is a critical component in tissue
engineering because it provides the three-dimensional clues for cell seeding, migration and growth,
and also for new tissue formation.
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Although the radiopacity of the augmented volume increased with time for both xenograft
materials, the receiving control sites showed a higher density of radiopacity compared with the PBM.
Maxillary sinus membrane preservation is important to avoid the displacement of graft materials into
the sinus cavity. However, nonobserved small perforations can imply a risk if left untreated.
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2.3. ISQ Results
Primary implant stability in relation with bone density can also be evaluated by the implant
stability quotient (ISQ). Detailed distributions for the implants and ISQ values over the investigated
time periods are depicted in Table 2. Three implants were not osseointegrated at the end of the study,
which left 57 implants for controls (a 95% success rate). Dropouts were not observed during the
evaluation period.
Table 2. Demographic data.
Number of Patients (Total) 10
Number of Implants (Total) 60
Osseointegrated (%) 57 (95)
Non Osseointegrated 3 (5)
Vestibule-Lingual (ISQ Values)
T1 T2 T3
PBM BBM PBM BBM PBM BBM
Mean 62.4 63.4 66.9 73.9 72.6 73.8
SD 2.92 2.88 2.67 4.11 7.67 2.99
Median 62.5 63.2 66.6 70.6 73.7 74
Mesio-Distal (ISQ Values)
T1 T2 T3
PBM BBM PBM BBM PBM BBM
Mean 62.8 64.2 67.1 75.2 74.2 74.2
SD 3.23 3.18 2.33 4.29 7.59 3.01
Median 62.5 64.8 69.1 72.4 75.8 75.5
ISQ: Implant stability quotient; T1: baseline; T2: at three months; T3: at six months, and the means and standards
deviation of the ISQ values.
The ISQ (Baseline) averaged values were 63.8 ± 2.97 for a sintered BBM and 62.6 ± 2.11 for a
non-sintered PBM, and differences were statistically significant. The ISQ (Stage 2) average values
were 73.5 ± 4.21 for the BBM and 67 ± 4.99 for the PBM, and differences were statistically significant.
The ISQ (Stage 3) average values were 74.65 ± 2.93 for the BBM and 72.9 ± 2.63 for the PBM, and
differ nc s wer st tistic lly significant. The detailed distributions for the groups are depicted in
Figure 4. The analysis of variance demonstrated a statistically significant difference (p < 0.0001).
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In the vestibule-lingual direction, the mean and standard deviation ISQ values measured at
Baseline, Stage 2, and Stage 3 were 63.4 ± 2.88, 73.9 ± 4.11, and 73.8 ± 2.99, respectively, for the BBM,
and were, respectively, 62.4 ± 2.92, 66.9 ± 2.67, and 72.6 ± 7.67 for the measured PBM ISQ values.
In the mesio-distal direction, the mean and standard deviation ISQ values measured at Baseline,
Stage 2, and Stage 3 were 64.2 ± 3.18, 75.2 ± 4.29, and 74.2 ± 3.01, respectively, for the BBM, and were,
respectively, 62.8 ± 3.23, 67.1 ± 2.33, and 74.2 ± 7.59 for the measured PBM ISQ values.
The multivariate regression analysis (R2 adjusted = 0.58, multiple correlation coefficient = 0.78)
demonstrated significant influences on the ISQ values in relation to age (p = 0.0120; r = −0.13), gender
(p < 0.0001; r = −0.48), group (p = 0.0017; r = 0.16), position (p = 0.0002; r = 0.19), and time (p < 0.0001;
r = 0.69).
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3. Discussion
This clinical study describes a comparison of the RFA of implants placed and delayed with
maxillary sinus grafting with two biomaterials deproteinized at different temperatures during three
distinct time periods. Sixty implants were fitted in 10 patients. Three implants were lost throughout the
study time period, and the survival rate of dental implants in the present study was 95%. The results
also showed a positive correlation between the used biomaterial and the ISQ values. The results
of a systematic review of the survival of implants in bone grafts, Aghaloo and Moy, found that the
survival of implants by the maxillary sinus grafting technique was 95.6% [2]. Presently, no agreement
about the advantages of using grafting material in maxillary sinus elevation techniques with dental
implant insertions has been reached because the question whether these techniques and materials
may determine implant survival, compared to pristine bone, remains unsolved [34,35]. To find the
answer to this question, long-term stability up to 20.2 years was retrospectively examined after the
placement of implants at both augmented and non augmented sites. The results of this retrospective
study determined that the implants inserted into an augmented site had a similar implant survival
to those inserted into non augmented sites [36]. Based on evidence, it can be stated that the implants
inserted into augmented bone offer a similar implant survival to those placed in native bone [37].
In our study the implicated grafting material might not compromise implant survival.
For clinicians, one of the most important parameters to measure the scope of mechanical loading
capability is implant stability. The baseline information that it provides serves as a tool to evaluate
clinical outcomes and time courses [28]. Several attempts have been made to find innovative
techniques that allow implant stability to be measured [27]. An RFA, which is a non-invasive
technique that presents highly reproducible results, has been proposed [23,38,39]. This technique
has become one of the most widely used techniques to measure implant stability immediately,
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which makes determining the probable loading protocol and assessing the long-term survival of
implants possible [25]. The comparison of the type of bone graft and initial implant stability was
performed herein. The results of this study showed that the implants placed and delayed (two-stage)
with the maxillary sinus lift with different biomaterials presented distinct ISQs, with statistically
significant differences.
From a clinical point of view, it would appear relevant to know the significance of RFA
measurements and the relationship between their values and implant osseointegration success or
failure. A previous study has observed that implants retrieved after 6 months show a strict correlation
between the RFA values and the percentage of bone implant contact (BIC) [40]. The aim of the present
study was to determine whether the same correlation existed at earlier time points, specifically in
implants inserted after three or six months. A statistically significant correlation was detected between
the RFA values and healing time. During the bone-healing period, the implants’ ISQ value varied
with time. In the surgical phase (baseline), the average ISQs for all the implants were 63.8 ± 2.97 for
a sintered BBM, and 62.6 ± 2.11 for a non sintered (PBM), with statistically significant differences.
The ISQ (Stage 2) average values were 73.5 ± 4.21 for the BBM and 67 ± 4.99 for the PBM, where
differences were statistically significant. The ISQ (Stage 3) average values were 74.65 ± 2.93 for the
BBM and 72.9 ± 2.63 for the PBM, with statistically significant differences.
The present study examined the same implants three and six months after their installation for the
implants inserted by a two-step procedure. The RFA values after three months showed that the grafted
sites provided good implant stability and, on average, the BBM were better than the PBM group sites.
This difference was still present after 6 months and was also statistically significant. The importance
of bony quality in relation to implant stability has been previously highlighted. Given the relative
lack of bone, there is some concern about the initial stability of the implants placed in grafted bone.
An RFA enables the stability under load to be qualitatively measured, and has been advocated as a
means of assessing implant stability at the time of placement and in later phases when providing
restorations [41].
This is the first study to compare ISQs with density values after sinus lift procedures six months
after healing and primary stability. The primary initial stability (IS) is a crucial factor to establish
osseointegration [42–44], and might be subject to the influence of the following factors: bone quality,
surgery technique, and implant macrodesign [44].
The above studies have demonstrated a strong correlation between implant displacement and
bone properties, and have concluded that better bone quality leads to better implant stability. Al-Khaldi
has also proven that implants with a high degree of density placed in bone have higher initial stability
values than those placed in soft bone [45], according to the results of insertion torque (IT), ISQs
and removal torque values (RTV) [46]. However, ISQs can improve through changes in the implant
macrodesign [47]. Moreover, when using a different drilling protocol in soft bone, Sennerby et al.
confirmed that when comparing tapered implants with parallel implants, the former showed a higher
primary stability than the latter [48].
A previous study on the same pool of implants used in our study (tapered implants) demonstrated
that grafted bone can offer good primary stability to implants and that, during the surgical procedure,
only a few mechanical characteristics of implants (length and diameter) were able to influence ISQ
values [49]. Degidi et al. have suggested that the length and width of implants can influence
primary stability because of the increased bone-implant contact surface area [50]. In the present
study, the macrodesign, and the length and diameter of the implant were not used as evaluation
factors as all the used implants were 4 mm in diameter and 11.5 mm in length, with tapered internal
hexagon implants, and are consistent with these studies, which report no statistically significant
differences in ISQ due to ISQ length or diameter [51,52]. From the clinical point of view, implants
that have been placed in soft or grafted bone show better mechanical stability values when they have
a narrow diameter and a tapered macrodesign [53,54]. In fact nearly every implant company offers
tapered-design implants for alveolar ridges with deficient bone quality and quantity.
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This should be taken into account for alveolar ridges with deficiencies in bone quality and quantity,
which is the reason why almost every company in the sector has introduced tapered-design implants.
In our study we used a small particle size of two different deproteinized bone grafts. Jensen et al.
evaluated the influence of the particle size of DBBM on bone formation and implant stability when
used for sinus floor elevation in a mini-pig model. In the initial healing phase, small particle size
DBBM showed marginally higher osteoconductive capacity than large particle size DBBM. However,
no differences were observed in the amount and speed of bone formation, BIC or implant stability
between the two test groups. However at the baseline and at six and 12 weeks, the BIC values were
comparable, or even higher, than in our study in humans. Primary implant stability is dependent on
not only the thickness of the bone into which the implant is placed, but also on bone density, thread
configuration, and implant shape, and the presence of an implant neck. Therefore, all these factors
should be taken into account when making the clinical decision to perform a one-stage or a two-stage
procedure [55].
As evidenced in the review of Browaeys et al. on using biomaterials in sinus augmentation,
within the limitation of the animal studies examined, and based only on histological examinations,
the biomaterial used in the grafting procedure does not influence the initial osseointegration of dental
implants [56].
The correlation between the RFA values and good bone quality reported herein seemed to confirm
the different importances of the factors that determine RFA values upon implant insertion and if it
is able to maintain this stability after three or six months. In fact, good quality bone probably reacts
better to implant insertion, and implant stability after bone remodeling could be greater.
Long-term stability has also been reported by Hallman et al. In their study 108 dental implants
were placed six months after sinus floor augmentation with a mixture of autogenous and deproteinized
bovine bone. After three years of loading, implant stability was recorded using an Osstell instrument.
The mean reported RFA values were 67.4 ± 14.5 for residual bone and 65.6 ± 13.8 for the augmented
sites. Unfortunately, no more data are currently available about the importance of bone quality in
determining long-term RFA values, so more studies have to be conducted [57].
Healing times of 6–9 months before implant placement are usually recommended for sinus
elevation in combination with grafting material [58], and an additional 3–6-month period of implant
healing time is needed. However, extended integration periods and multiple surgeries pose a challenge
for patient acceptance [59].
Our results also indicate that regardless of the substitute material, the implants inserted into
a grafted sinus can be predictably loaded as the implants inserted into a grafted area. Previous
studies have concluded that the prognosis of implants inserted into augmented sinuses and the fixed
restoration supported by these implants do not appear to be influenced by factors, such as graft
material, restoration type, residual bone height, and time of implant placement. Within the limits
of this review, the prognosis of implants and fixed restorations did not seem to be influenced by
the restoration type, graft material, residual bone height, and time of implant placement. However,
the conclusions of this review are based on studies that provide a low level of evidence. Therefore,
careful interpretations are required. Multicenter randomized controlled clinical trials with sufficient
statistical power that concentrate on a few factors are needed to draw sound conclusions [11].
The differences between the two HAs, in porosity, crystallinity, density, surface area and
composition terms, may determine different behaviors of this material, and might affect early implant
stability in this clinical situation. The HA of a bovine origin sintered with high crystallinity, low porosity,
high density, and a larger granule size presents better stability, which demonstrates that variations
in the physico-chemical properties of a bone substitute material clearly influence implant stability.
A profound knowledge of the graft material characteristics is of utmost importance when assessing
their clinical outcomes. The physico-chemical properties of bone substitute materials can influence
osseointegration and shorten healing times from implant placement to restoration. Understanding not
only the biomaterial properties, but also their relation and influence on bone healing, seems crucial.
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4. Materials and Methods
4.1. Commercial Xenograft Materials
The commercial graft materials used in this study were two different types of bone deprotenized
hydroxyapatite materials of diferent origins employed in dentistry: deproteinized porcine bone mineral
hydroxyapatite (PBM), called OsteoBiol® (OsteoBiol, Tecnoss Dental SRL, Torino, Italy); deproteinized
bovine hydroxyapatite (BBM), called Endobon® (RegenerOss™, BIOMET3i, Palm Beach, FL, USA).
The physico-chemical and morphological characterizations of both xenograft materials are found in a
previous study [33].
4.2. Implant Procedure
4.2.1. Patient Selection and Protocol
Ten partially-edentulous patients (five females and five males), whose ages ranged from 37
to 60 years, attended the Department of Oral and Maxillofacial Surgery. Patients who demanded
fixed restorative appliances in the posterior maxilla were selected for maxillary sinus augmentation
because sufficient bone tissue was lacking to place endosseous dental implants. The protocol for
harvesting bone samples was approved by the University Ethics Committee and informed consent
was obtained from all the patients (UCAM-Ethics Committee, approval ID: 6637). The study was
designed following the Declaration of Helsinki guidelines for experimentation on human subjects.
Any possible complications that could arise from surgical therapy were treated following standard
dental management protocols.
4.2.2. Inclusion and Exclusion Criteria
Atrophy of the lateral-posterior maxilla and residual crestal bone height was classified according
to Cawood et al.’s subsummizing classes I–VI. All of the patients underwent CBCT before surgery as a
routine diagnostic approach to carefully evaluate the available bone at the intended surgical site and
for planning the grafting procedure.
The inclusion criteria were as follows: maxillary partial bilateral edentulism that involves
premolar-molar areas. The cases with a crestal bone height between 7 mm and 0 mm, and with
high postero-lateral atrophy (Cawood V–VI), are most likely to undergo a two-stage lateral antrostomy.
The exclusion criteria were: patients who suffer from an uncontrolled systemic disease or
a condition known to alter bone metabolism (i.e., osteoporosis, diabetes mellitus, etc.); subjects
who were taking/had taken medications known to modify bone metabolism; e.g., bisphosphonates,
corticosteroids, etc.; women who were pregnant or trying to get pregnant at the time of screening;
patients who presented existing sinus conditions, sepsis, a history of cancer and/or radiation to the
oral cavity; or complications derived from any of these conditions that affect the sinus area.
4.2.3. Surgical Procedure. First Phase
The study was performed in two surgical phases. In the first phase all the patients took 875/125 mg
of amoxycillin/clavulanic acid every 8 h starting one day before surgery. A 300-mg dose of clindamycin
every 8 h was prescribed to penicillin-allergic patients. This medication was maintained for seven
days. All of the surgical procedures were performed under local anesthesia (Ultracain, Aventis Inc.,
Frankfurt, Germany). The basic surgical procedure was represented in all the patients by maxillary
sinus floor elevation via a lateral approach, as described by Boyne and James (Figure 5).
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Figure 5. A lateral window is prepared and the Schneiderian membrane is elevated.
After membrane elevation, a bioabsorbable collagen barrier membrane was placed under the sinus
membrane and adapted to come into contact with peripheral bony walls (Evolution Fine, OsteoBiol®,
Tecnoss Dental S.R.L., Torino, Italy). Sinuses were allocated to the non-sintered HAs (PBM) or to the
sintered HAs (BBM) group via a standard randomization protocol (http://www.randomization.com).
On one side, sinus cavities were grafted with the PBM (OsteoBiol® mp3, Tecnoss Dental S.R.L., Torino,
Italy). After grafting, an absorbable collagen membrane (Evolution Fine®, OsteoBiol®, Tecnoss Dental
S.R.L., Torino, Italy) was placed over the window to minimize soft tissue invasion. On the other
side, sinus cavities were grafted with the BBM (Endobon®, RegenerOss™, BIOMET3i, Palm Beach
Gardens, FL, USA). The grafting materials were mixed with venous blood from the defect area and
were carefully packed in the created volume following mucous membrane elevation. After bone
grafting, a short-term absorbable collagen membrane (Evolution Fine, OsteoBiol®, Tecnoss Dental
S.R.L., Torino, Italy) was placed over the window. Primary closure was achieved in both cases by
suturing with 3–0 silk suture (Laboratory Aragón, Barcelona, Spain). Sutures were removed two weeks
after surgery. During the postoperative period, patients were clinically and radiologically followed up
at monthly intervals (Figure 6).
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4.2.5. Surgical Procedure: Second Phase—Implant Insertion
The second surgical phase was performed after the healing period. Functional implants were
placed on each side. Each side received three implants (3i T3®, Certain Tapered Internal Connection
Implants, BIOMET 3i™, Palm Beach Gardens, FL, USA) placed six months after augmentation. All of
the patients took 875 mg/125 mg units of amoxycillin/clavulanic acid every 8 h starting one day
before surgery. A dose of 300 mg of clindamycin every 8 h was prescribed to penicillin-allergic patients.
This medication was maintained for seven days. All of the surgical procedures were performed under
local anesthesia (Ultracain, Aventis Inc., Frankfurt, Germany) in an outpatient setting by the same
surgeon, who was familiar with the implant system. For the procedure, a full thickness mucoperiosteal
flap was elevated on the sides. The osteotomy using a conical drill, with copious irrigation using saline
solution, was done on the crest of the bone. Then osteotomies for fitting implants were produced using
the initial drill to determine the depth and direction of the site. Afterward, implants were positioned in
the local area, predetermined at the crestal bone level. Sixty conical implants with an internal hexagon
connection were applied, which were all 11.5 mm long with a 4.0 mm diameter. Implants were selected
according to the prior evaluation of each case. All the implants were fitted using surgical guides, and
wounds were sutured in a tension-free state. Antibiotics and analgesics were given for one week. All of
the patients took 875/125 mg of amoxycillin/clavulanic acid every 8 h starting one day before surgery,
and 300 mg of Clindamycin every 8 h werre prescribed to penicillin-allergic patients. This medication
was maintained for seven days. Patients were asked to rinse with 0.12% chlorhexidine three times
daily for two postoperative weeks. Sutures were removed two weeks after surgery. All of the implants
were prepared with a healing abutment until rehabilitation commenced.
4.3. Measuring Implant Stability
After dental implant insertion, the resonance frequency evaluation was made using the Ostell™
Mentor (Integration Diagnostics AB, Göteborg, Sweden) to measure the implant’s primary stability.
A Smartpeg™ (Integration Diagnostics AB, Göteborg, Sweden) was placed in each implant and was
tightened to approximately 4–5 Ncm. The transducer probe was aimed at the small magnet at the top
of the Smartpeg and at a distance of 2–3 mm, and was held stable during pulsing until the instrument
beeped and displayed the ISQ value (Figure 8). The RF value is represented by a quantitative parameter
called ISQ. The ISQ range went from 1 to 100. An increased ISQ indicates increased stability, whereas
low values indicate reduced implant stability. The ISQ values were measured during the surgical
procedure (T1-baseline), at three months (T2) after surgery, and at six months (T3) after surgery.
Measurements were taken twice in the bucco-lingual direction and twice in the mesio-distal direction.
The mean of the two measurements in each direction was regarded as the representative ISQ for that
direction. The higher values were recorded for the bucco-lingual (B-L) direction and the mesio-distal
(M-D) direction. The ISQ values were separately evaluated. Each implant was also evaluated during
all visits for mobility, pain and signs of infection.
Materials 2017, 10, 644 12 of 15
Materials 2017, 10, 644  11 of 15 
 
Implants, BIOMET 3i™, Palm Beach Gardens, FL, USA) placed six months after augmentation. All of 
the patients took 875 mg/125 mg units of amoxycillin/clavulanic acid every 8 h starting one day before 
surgery. A dose of 300 mg of clindamycin every 8 h was prescribed to penicillin-allergic patients. This 
medication was maintained for seven days. All of the surgical procedures were performed under 
local anesthesia (Ultracain, Aventis Inc., Frankfurt, Germany) in an outpatient setting by the same 
surgeon, who was familiar with the implant system. For the procedure, a full thickness 
mucoperiosteal flap was elevated on the sides. The osteotomy using a conical drill, with copious 
irrigation using saline solution, was done on the crest of the bone. Then osteotomies for fitting 
implants were produced using the initial drill to determine the depth and direction of the site. 
Afterward, implants were positioned in the local area, predetermined at the crestal bone level. Sixty 
conical implants with an internal hexagon connection were applied, which were all 11.5 mm long 
with a 4.0 mm diameter. Implants were selected according to the prior evaluation of each case.  
All the implants were fitted using surgical guides, and wounds were sutured in a tension-free state. 
Antibiotics and analgesics were given for one week. All of the patients took 875/125 mg of 
amoxycillin/clavulanic acid every 8 h starting one day before surgery, and 300 mg of Clindamycin 
every 8 h werre prescribed to penicillin-allergic patients. This medication was maintained for seven 
days. Patients were asked to rinse with 0.12% chlorhexidine three times daily for two postoperative 
weeks. Sutures were removed two weeks after surgery. All of the implants were prepared with a 
healing abutment until rehabilitation commenced. 
4.3. Measuring Implant Stability 
After dental implant insertion, the resonance frequency evaluation was made using the Ostell™ 
Mentor (Integration Diagnostics AB, Göteborg, Sweden) to measure the implant’s primary stability. 
A Smartpeg™ (Integration Diagnostics AB, Göteborg, Sweden) was placed in each implant and was 
tightened to approximately 4–5 Ncm. The transducer probe was aimed at the small magnet at the top 
of the Smartpeg and at a distance of 2–3 mm, and was held stable during pulsing until the instrument 
beeped and displayed the ISQ value (Figure 8). The RF value is represented by a quantitative 
parameter called ISQ. The ISQ range went from 1 to 100. An increased ISQ indicates increased 
stability, whereas low values indicate reduced implant stability. The ISQ values were measured 
during the surgical procedure (T1-baseline), at three months (T2) after surgery, and at six months 
(T3) after surgery. Measurements were taken twice in the bucco-lingual direction and twice in the 
mesio-distal direction. The mean of the two measurements in each direction was regarded as the 
representative ISQ for that direction. The higher values were recorded for the bucco-lingual (B-L) 
direction and the mesio-distal (M-D) direction. The ISQ values were separately evaluated. Each 
implant was also evaluated during all visits for mobility, pain and signs of infection. 
 
Figure 8. (A) Implant-bone contact rigidity was measured by RFA (Osstell™ Mentor, Integration 
Diagnostic AB, Sweden). RFA measurements were obtained before the healing cape was screwed into 
implant fixtures; (B) A Smartpeg (Smartpeg™, Integration Diagnostic AB, type 4 regular neck) was 
attached manually to the fixture with the help of a mount, and a torque of 4–5 Ncm was applied;  
(C) All the measurements were taken out by the same researcher. Measurements were taken at the 
time of implant placement and (baseline) at Stages 2 and 3. In all cases, an ISQ was calculated as the 
average of four measurements per implant (twice in the bucco-lingual direction and twice in the 
mesio-distal direction). 
Figure 8. (A) Implant-bone contact rigidity was measured by RFA (Osstell™ Mentor, Integration
Diagnostic AB, Sweden). RFA measurements were obtained before the healing cape was screwed
into implant fixtures; (B) A Smartpeg (Smartpeg™, Integration Diagnostic AB, type 4 regular neck)
was attached manually to the fixture with the help of a mount, and a torque of 4–5 Ncm was applied;
(C) All the easure ents ere taken out by the sa e researcher. easure ents ere taken at the
ti e of i plant place ent and (baseline) at Stages 2 and 3. In all cases, an ISQ was calculated as
the average of four measurements per implant (twice in the bucco-lingual direction and t ice in the
esio-distal direction).
4.4. Statistical Evaluation
All of the data were recorded, reviewed, and inputted into a computing system. Analyses were
performed using specific software (MedCalc v15.8, Ostend, Belgium). The influence of age, gender
(male, female), group (BBM, PBM), ISQ measurement direction (BL, MD), and the evaluation time
period, (T1) baseline, (T2) three months, abnd (T3) six months, on the ISQ values was evaluated by an
analysis of variance (ANOVA) and multiple regression at the 5% significance level (backward method)
with the help of appropriate software (MedCalc v15.8, Ostend, Belgium).
5. Conclusions
The differences between the two HAs found in porosity, crystallinity, density, surface area, and
composition terms may determine the different behaviors of this material and might affect early implant
stability in this clinical situation. The HA of a bovine origin (BBM) sintered with high crystallinity
and low porosity presents better stability, which demonstrates that variations in the physico-chemical
properties of a bone substitute material clearly influence implant stability. Detailed information about
the graft material’s characteristics is crucial to evaluate its clinical outcomes. The influence of the
physico-chemical properties of bone graft materials on osseointegration has led to shorter healing
times from implant placement to restoration. A sound understanding of various aspects of biomaterial
properties, and their relation to and influence on bone healing, is of utmost importance.
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